Literature DB >> 7917077

Bioinequivalence and drug toxicity. How great is the problem and what can be done?

C H Gleiter1, U Gundert-Remy.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1994        PMID： 7917077     DOI： 10.2165/00002018-199411010-00001

Source DB:  PubMed          Journal:  Drug Saf        ISSN： 0114-5916            Impact factor:   5.606


× No keyword cloud information.
  25 in total

1.  Bioequivalence studies: single vs multiple dose.

Authors:  V W Steinijans; R Sauter; J H Jonkman; H U Schulz; H Stricker; H Blume
Journal:  Int J Clin Pharmacol Ther Toxicol       Date:  1989-05

2.  Generic carbamazepine and erythema multiforme: generic-drug nonequivalency.

Authors:  R L Busch
Journal:  N Engl J Med       Date:  1989-09-07       Impact factor: 91.245

3.  Aspects for bioavailability and bioequivalence revision: possible implications on clinical pharmacology.

Authors:  W A Ritschel
Journal:  Methods Find Exp Clin Pharmacol       Date:  1987-07

4.  Therapeutic non-equivalence of digoxin tablets in the United Kingdom: correlation with tablet dissolution rate.

Authors:  T R Shaw; K Raymond; M R Howard; J Hamer
Journal:  Br Med J       Date:  1973-12-29

5.  Variation in biologic availability of digoxin from four preparations.

Authors:  J Lindenbaum; M H Mellow; M O Blackstone; V P Butler
Journal:  N Engl J Med       Date:  1971-12-09       Impact factor: 91.245

6.  Outbreak of anticonvulsant intoxication in an Australian city.

Authors:  J H Tyrer; M J Eadie; J M Sutherland; W D Hooper
Journal:  Br Med J       Date:  1970-10-31

7.  Clinical and statistical issues in therapeutic equivalence trials.

Authors:  E Garbe; J Röhmel; U Gundert-Remy
Journal:  Eur J Clin Pharmacol       Date:  1993       Impact factor: 2.953

8.  Bio-International 92, conference on bioavailability, bioequivalence, and pharmacokinetic studies.

Authors:  H H Blume; K K Midha
Journal:  J Pharm Sci       Date:  1993-11       Impact factor: 3.534

9.  Evaluation of methods for estimating population pharmacokinetic parameters. II. Biexponential model and experimental pharmacokinetic data.

Authors:  L B Sheiner; S L Beal
Journal:  J Pharmacokinet Biopharm       Date:  1981-10

10.  Bioinequivalence of a generic brand of diazepam.

Authors:  A Locniskar; D J Greenblatt; J S Harmatz; R I Shader
Journal:  Biopharm Drug Dispos       Date:  1989 Nov-Dec       Impact factor: 1.627
View more
  4 in total

Review 1.  [Original brands and generic preparations].

Authors:  K U Petersen
Journal:  Med Klin (Munich)       Date:  2000-01-15

2.  Does knowledge of medication prices predict physicians' support for cost effective prescribing policies.

Authors:  Jennifer M Polinski; Malcolm Maclure; Blair Marshall; Alan Cassels; Jessica Agnew-Blais; Amanda R Patrick; Sebastian Schneeweiss
Journal:  Can J Clin Pharmacol       Date:  2008-07-19

3.  Exploring the opinions and experiences of patients with generic substitution: a representative study of Polish society.

Authors:  Aleksandra Drozdowska; Tomasz Hermanowski
Journal:  Int J Clin Pharm       Date:  2014-11-27

4.  Patient-reported outcomes of therapy with two brands of ibuprofen.

Authors:  Lucky L Nwidu; Joshua F Eniojukan; Azuka C Oparah
Journal:  Pharm Pract (Granada)       Date:  2008-09-15
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.